Summary.-S.c. injection of tumour cells or small pieces of tumour irradiated to a dose of 22,000 rad evoked resistance to live challenge with the same tumour (a CBA strain fibrosarcoma induced with methylcholanthrene) 14 days later. This resistance was, however, over-ridden if the challenging inoculum was sufficiently large, and did not develop if the cells were irradiated to 100,000 rad.
IT was reported by Woodruff and Dunbar (1973) that simultaneous s.c. injection of irradiated tumour cells and i.p. injection of C. parvum to mice with small but actively growing fibrosarcoma isotransplants caused a more prolonged remission than either treatment alone. On the other hand Smith and Scott (1972) found that administration of C. parvum 7 days before immunization with irradiated tumour cells diminished the protective effect of the immunization, as judged by the effect of subsequent challenge with viable tumour cells.
Taken together, these findings have important implications both for our understanding of the mode of action of C. parvum as an immunopotentiating agent and in relation to the possible use of C. parvum in combination with active specific immunization for the treatment of patients with cancer. The present experiments were therefore undertaken to see whether the observations of Smith and Scott could be repeated with our tumour system. As a preliminary we have studied the effect of variations in the preparation of the irradiated tumour material, the route of injection, and the quantity injected, on immunization in the absence of C. parvum.
MATERIALS AND METHODS
Mice.-7-9 week-old female CBA mice were used throughout.
Tumour.-The tumour was a fibrosarcoma induced in a CBA female mouse with methylcholanthrene, and was in its 15th-17th transplant generation. In most of the experiments, we have used tumour cell suspensions prepared with pronase as described previously (Woodruff, Inchley and Dunbar, 1972) , but for immunization we have also used small pieces of recently excised tumour. Tumour cells and pieces of tumour used for immunization were irradiated with a Westinghouse x-ray machine operating at 220 kV and 15 ma with HVL of 1-2 mm Cu under conditions of maximum back scatter, at a dose rate of 274 rad/min.
Assessment of results.-The results were assessed by comparing the incidence of tumours and relative growth rates in the various treatment groups.
Differences in the incidence of tumours were often so clear-cut as to make statistical analysis unnecessary, but when this was not the case the probability (P) of the observed difference being due to random sampling, from published values applicable (unless otherwise stated) to a single-tailed test for fourfold tables (Diem and Lentner, 1970) It thus appears that, under the conditions of the experiment, the resistance normally evoked by pretreatment with irradiated cells was completely abrogated by a large i.p. injection of C. parvum 11 days after the cells and partly abrogated by a similar injection 5 days before the cells.
All mice which received 106 irradiated cells mixed with 0 7 mg C. parvum developed tumours after challenge with 105 or 107 viable cells, and the mean relative growth rate was the same after 107 cells, and only marginally less after 105 cells, than in the corresponding untreated controls. After challenge with 104 viable cells, however, the incidence of tumours in the treated mice was significantly less than in the controls (comparing groups 9 and 1 of Table II after challenge with 104 viable cells: P = 0-001). It thus appears that at this dosage C. parvum abrogated the development of resistance to a great extent but not completely. Smaller doses had little effect. A dose of 0 35 mg (Table II, instead of abrogation, immunization may actually be enhanced. When the dose is still further reduced there is no effect in either direction.
Our attempts to elucidate the mechanism underlying this phenomenon are as yet inconclusive. As we have already briefly reported (Woodruff, Ghaffar and Dunbar, 1975) , spleen cells from mice pretreated with C. parvum and irradiated tumour cells may be cytotoxic for the tumour in vitro even though the mice show no increased resistance to challenge with viable tumour cells. In the light of this finding we suggested that the abrogation of resistance in vivo might be caused by a blocking factor in the serum, and preliminary experiments appeared to lend some support to this conjecture. We do not know, however, to what extent, if any, the cell-mediated cytotoxicity in vitro is specific for the tumour, and further investigation has failed to confirm the existence of a blocking factor. Another possibility, which is currently being investigated, is that administration of C. parvum under the conditions of the experiment results in the development of suppressor T-cells. For the time being, however, the question of mechanism must be regarded as 8ub judice. This study was supported by grants from the Cancer Research Campaign.
